Lack of neuroprotection by an ACTH (4–9) analogue. A randomized trial in patients treated with vincristine for Hodgkin’s or non-Hodgkin’s lymphoma

By Koeppen S.   Verstappen C.   Körte R.   Scheulen M.   Strumberg D.   Postma T.   Heimans J.   Huijgens P.   Kiburg B.   Renzing-Köhler K.   Diener H.  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 3, 2004-03 ,pp. : 153-160

Springer Publishing Company

Access to resources Recommend Favorite

Clinical randomized comparative trial of DICE regimen and CHOP regimen in treating intermediate and high grade non-Hodgkin's lymphoma

By Wang Wenwu  

The Chinese-German Journal of Clinical Oncology, Vol. 7, Iss. 2, 2008-02 ,pp. : 107-110

Springer Publishing Company

Access to resources Recommend Favorite

Primary non-Hodgkin’s lymphoma of the breast treated nonsurgically: report of three cases

By Ogawa Toshihisa  

Breast Cancer, Vol. 18, Iss. 1, 2011-01 ,pp. : 68-72

Springer Publishing Company

Access to resources Recommend Favorite

Reactivation of hepatitis B virus infection with cytotoxic therapy in non-Hodgkin’s lymphoma

By Ozguroglu M.   Bilici A.   Turna H.   Serdengecti S.  

Medical Oncology, Vol. 21, Iss. 1, 2004-03 ,pp. : 67-72

Humana Press, Inc

Access to resources Recommend Favorite

Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin’s lymphoma

By Kilickap Saadettin   Yavuz Bunyamin   Aksoy Sercan   Sahiner Levent   Dincer Murat   Harputluoglu Hakan   Erman Mustafa   Aytemir Kudret   Tokgozoglu Lale   Barista Ibrahim  

Medical Oncology, Vol. 25, Iss. 4, 2008-12 ,pp. : 437-442

Humana Press, Inc

Access to resources Recommend Favorite